Target intelligence / Profile preview

Hepatic lipid transport proteins

Molecular classification
Transporter, ATP-binding cassette transporter, Fatty acid transport protein, Lipoprotein
01

Overview

Hepatic lipid transport proteins encompass a diverse family of transporters that facilitate the movement of lipids into, out of, and within liver cells. Key members include the ATP-binding cassette transporters ABCA1, ABCG1, and ABCG5/G8, which mediate cholesterol efflux and sterol transport, and fatty acid transport proteins (FATPs) such as FATP2, FATP4, and FATP5 that facilitate fatty acid uptake through acyl-CoA synthetase activity. ABCA1 plays a crucial role in reverse cholesterol transport by transferring cholesterol and phospholipids from hepatocytes to HDL particles. ABCG5/G8 transporters form heterodimers that pump cholesterol and plant sterols into bile for excretion. FATPs, particularly FATP2 and FATP5, are involved in hepatic fatty acid uptake and when dysregulated can contribute to hepatic steatosis. These proteins are essential for maintaining hepatic lipid homeostasis and their altered expression is associated with metabolic disorders including non-alcoholic fatty liver disease, insulin resistance, and cardiovascular disease. The coordinated function of these transport systems enables the liver to serve its central role in whole-body lipid metabolism, including the synthesis and secretion of lipoproteins, bile acid production, and the processing of dietary and peripheral lipids.

Other names
Liver lipid transport proteinshepatic lipid transportersliver fatty acid transport proteins
02

Mechanism of action

Facilitated diffusion of lipids, ATP-dependent lipid efflux, Vectorial acylation for fatty acid uptake, Cholesterol and phospholipid transfer between cellular compartments

03

Biological functions

Lipid transportFatty acid uptakeCholesterol effluxReverse cholesterol transportLipid metabolismCellular lipid homeostasis
04

Disease associations

Cardiovascular diseaseNon-alcoholic fatty liver diseaseMetabolic syndromeAtherosclerosisInsulin resistanceObesity
05

Safety considerations

Potential for hepatic steatosis with altered expressionRisk of insulin resistancePossible impact on bile acid metabolism
06

Biomarkers

HDL cholesterol levelsApolipoprotein A-I levelsLiver lipid content

Beyond the preview

Go deeper on Hepatic lipid transport proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatic lipid transport proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call